Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTp-SP versus IPTp-SP plus screen-and-treat with dihydroartemisinin-piperaquine in pregnant women in Nchelenge, Zambia
ISRCTN45944555Phase 3Completed
- Sponsor
- Tropical Diseases Research Centre
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sulfadoxine + pyrimethamine and dihydroartemisinin + piperaquine in Placental Malaria (PM) (2 arms), sponsored by Tropical Diseases Research Centre. Primary endpoints: Mean birth weight and Low birth weight prevalence. Started May 2024; status: completed.
02
Drugs
sulfadoxine + pyrimethaminedihydroartemisinin + piperaquine
03
Conditions
Placental Malaria (PM)
Beyond the preview
Go deeper on ISRCTN45944555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN45944555.